// App-Quantinova.ai

AB0500 (2017) : TOLERABILITY, EFFICACY AND IMMUNOGENICITY OF 23-VALENT PNEUMOCOCCAL VACCINE IN SLE PATIENTS

Researchers

Presenter

  • G.M. Tarasova

Principal Investigators

  • B.S. Belov

  • M.S. Sergeeva

  • S.K. Soloviev

  • E.A. Aseeva

  • N.G. Klukvina

  • T.V. Popkova

  • E.N. Alexandrova

  • A.A. Novikov

  • M.V. Cherkasova

Medical Centers

  • VA Nasonova Institute of Rheumatology, Moscow, Russian Federation, Moscow, Russia

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Bone Morphogenetic Protein 1

Drug/Treatment

  • Pneumococcal polysaccharide vaccine

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved